Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (101-110 of 394) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|May 20, 2025
Management of Immune Tolerant Chronic Hepatitis BMai M Kilany, Milan J Sonneveld, Jordan J Feld, et al.
Gastroenterology|December 7, 2019
Challenges With Stopping Long-term Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis BK Seng Liem, Adam J Gehring, Jordan J Feld, et al.
Journal of Hepatology|April 28, 2022
Feasibility of hepatitis B elimination in high-income countries with ongoing immigrationFeng Tian, Jordan J Feld, Zeny Feng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2017
Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatmentJordan J Feld, Jean-Michel Pawlotsky, Fernando Tatsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2019
The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approachAysegul Erman, William W L Wong, Jordan J Feld, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
Race or genetic makeup for hepatitis C virus treatment decisions?Thomas R O'Brien, Shyam Kottilil, Jordan J Feld, et al.
Viruses|August 26, 2022
HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus InfectionMuhammad Atif Zahoor, Adrian Kuipery, Alexander I Mosa, et al.
Journal of Hepatology|January 22, 2014
Reply to: 'Evidence recommending antiviral therapy in hepatitis C'Adriaan J van der Meer, Jordan J Feld, Stefan Zeuzem, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 14, 2015
Cost-effectiveness of screening for hepatitis C in CanadaWilliam W L Wong, Hong-Anh Tu, Jordan J Feld, et al.
Journal of Hepatology|June 1, 2022
Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmissionTatyana Kushner, Maya Djerboua, Mia J Biondi, et al.
Pageof 40

Showing results (101-110 of 394) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|May 20, 2025
Management of Immune Tolerant Chronic Hepatitis BMai M Kilany, Milan J Sonneveld, Jordan J Feld, et al.
Gastroenterology|December 7, 2019
Challenges With Stopping Long-term Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis BK Seng Liem, Adam J Gehring, Jordan J Feld, et al.
Journal of Hepatology|April 28, 2022
Feasibility of hepatitis B elimination in high-income countries with ongoing immigrationFeng Tian, Jordan J Feld, Zeny Feng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2017
Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatmentJordan J Feld, Jean-Michel Pawlotsky, Fernando Tatsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2019
The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approachAysegul Erman, William W L Wong, Jordan J Feld, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
Race or genetic makeup for hepatitis C virus treatment decisions?Thomas R O'Brien, Shyam Kottilil, Jordan J Feld, et al.
Viruses|August 26, 2022
HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus InfectionMuhammad Atif Zahoor, Adrian Kuipery, Alexander I Mosa, et al.
Journal of Hepatology|January 22, 2014
Reply to: 'Evidence recommending antiviral therapy in hepatitis C'Adriaan J van der Meer, Jordan J Feld, Stefan Zeuzem, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 14, 2015
Cost-effectiveness of screening for hepatitis C in CanadaWilliam W L Wong, Hong-Anh Tu, Jordan J Feld, et al.
Journal of Hepatology|June 1, 2022
Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmissionTatyana Kushner, Maya Djerboua, Mia J Biondi, et al.
Pageof 40